However, sodium-glucose cotransporter 2 (SGLT2) inhibitors have serendipitously been found to markedly reduce the risk of heart failure in people with DM,10 showing that cardiac complications of DM are tractable. This evidence concerns the gene SLC5A2 and diabetes mellitus.